Please assess the completion status of the following clinical trial:

Trial Title: Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Polycystic Ovary Syndrome diagnosis (Rotterdam Criteria)~* Vitamin D insufficiency (serum Vitamin D \<30 ng/mL)~* Insulin resistance~* Mild or greater severity of depression by Beck Depression Inventory-II~Exclusion Criteria:~* Current metformin use~* Vitamin D supplementation of \> 50,000 IU following confirmation of Vitamin D insufficiency~* Insulin-dependent diabetes mellitus~* Pregnancy or breastfeeding~* Untreated hypothyroidism~* Current active substance abuse~* Other major medical comorbidity: renal or hepatic dysfunction, severe pulmonary~* Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Metformin (Type: EXPERIMENTAL): Metformin 1000 mg PO bid
- Vitamin D (Cholecalciferol) (Type: EXPERIMENTAL): Cholecalciferol 5,000 IU PO daily

Based on this trial design, predict the completion outcome and termination type (if applicable).